Name: UMIN ID:
Unique ID issued by UMIN | UMIN000041086 |
---|---|
Receipt number | R000046919 |
Scientific Title | Immune checkpoint inhibitors versus ramucirumab plus docetaxel for refractory or relapsed advanced non-small cell lung cancer: A systematic review and network meta-analysis of phase 3 randomized clinical trials. |
Date of disclosure of the study information | 2020/07/20 |
Last modified on | 2020/08/31 12:20:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/07/13 12:32:57 | ||
2 | Update | 2020/08/31 12:18:18 | Recruitment status Date of IRB |
|
3 | Update | 2020/08/31 12:20:11 | Number of participants that the trial has enrolled |